Health-related quality of life as prognostic factor for response, progression-free survival, and survival in women with metastatic breast cancer

Medical Oncology

Volumn 29, Issue 2, 2012, Pages 432-438

  Svensson, Helene ^a,b   Hatschek, Thomas ^c   Johansson, Hemming ^c   Einbeigi, Zakaria ^b   Brandberg, Yvonne ^d  

^a SAHLGRENSKA ACADEMY AT UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

EORTC QLQ C30; Health related quality of life; Metastatic breast cancer; Prognostic factor

Indexed keywords

CAPECITABINE; EPIRUBICIN; PACLITAXEL; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; DRUG DERIVATIVE; FLUOROURACIL;

ADVANCED CANCER; APPETITE DISORDER; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CONTROLLED STUDY; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; NAUSEA AND VOMITING; PAIN; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT RESPONSE; ADOLESCENT; ADULT; AGED; BREAST TUMOR; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE FREE SURVIVAL; FOLLOW UP; HEALTH STATUS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; EPIRUBICIN; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PACLITAXEL; PROGNOSIS; PROSPECTIVE STUDIES; QUALITY OF LIFE; SURVIVAL RATE; YOUNG ADULT;

EID: 84866299713     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-011-9844-9     Document Type: Article

References (26)

1. Kramer JA, et al. Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer. Eur J Cancer. 2000;36(12):1498-506.
2. Alexandre J, et al. Factors predicting for efficacy and safety of docetaxel in a compassionate use cohort of 825 heavily pretreated advanced breast cancer patients. J Clin Oncol. 2000;18(3):562-73.
3. Hakamies-Blomqvist L, et al. Prognostic value of quality of life scores for time to progression (TTP) and overall survival time (OS) in advanced breast cancer. Eur J Cancer. 2003;39(10):1370-6.
4. Wyld L, et al. Prognostic factors for patients with hepatic metastases from breast cancer. Br J Cancer. 2003;89(2):284-90.
5. Efficace F, et al. Helath-related quality of life parameters as prognostic factors in a non metastatic breast cancer population: an international multicenter study. J Clin Oncol. 2004;22(16): 3381-3.
6. Cianfrocca M, Goldstein L. Prognostic and predictive factors in early stage breast cancer. Oncologist. 2004;9(6):606-16.
7. Largillier R, et al. Prognostic factors in 1038 women with metastatic breast cancer. Ann Oncol. 2008;19(12):2012-9.
8. Coates A, et al. Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group. J Clin Oncol. 1992;10(12): 1833-8.
9. Efficace F, et al. Baseline health-related quality of life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer. Eur J Cancer. 2004;40(7):1021-30.
10. Winer EP, et al. Failure of higher dose paclitaxel to improve outcome in patients with metastatic breast cancer: cancer and leukemia group B trial 9342. J Clin Oncol. 2004;22(11):2061-8.
11. Quinten C, et al. Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncol. 2009;10(9):865-71.
12. Lee CK, et al. Self-reported health-related quality of life is an independent predictor of chemotherapy treatment benefit and toxicity in women with advanced breast cancer. Br J Cancer. 2010;102(9):1341-7.
13. Svensson H, Einbeigi Z, Johansson H, Hatschek T, Brandberg Y. Quality of life in women with metastatic breast cancer during nine months after randomization in the TEX trial (epirubicin and paclitaxel w/o capecitabine). Breast Cancer Res Treat. 2010; 123(3): 785-93.
14. Aaronson NK, et al. The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Ca Inst. 1993;85(5):365-76.
15. Fayers PM, et al. On behalf of the EORTC quality of life group, EORTC QLQ-C30 scoring manual. 3rd ed. Brussels: EORTC; 2001.
16. Michelson H, Bolund C, Nilsson B, Brandberg Y. Health-related quality of life measured by the EORTC QLQ-C30 reference values from a large sample of Swedish population. Acta Oncol. 2000;39(4):477-84.
17. Schemper M, Smith TL. A note on quantifying follow-up in studies of failure time. Control Clin Trials. 1996;17(4):343-6.
18. Sauerbrei W, Schumacher A. A boostrap resampling procedure for model building: application to the Cox regression model. Stat Med. 1992;11(16):2093-109.
19. Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998;16(1):139-44.
20. Portenoy RK, Itri LM. Cancer-related fatigue: guidelines for evaluation and management. Oncologist. 1999;4(1):1-10.
21. Servaes P, Verhagen C, Bleijenberg G. Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions. Eur J Cancer. 2002;38(1):27-43.
22. Heim ME, Malsbur ML, Niklas A. Randomized controlled trial of structured training program in breast cancer patients with tumor related chronic fatigue. Onkologie. 2002;30(8-9):429-34.
23. Dagnelie PC, et al. Impact of fatigue on overall quality of life in lung and breast cancer patients selected for high-dose radiotherapy. Ann Oncol. 2007;18(5):940-4.
24. Lee MK, et al. Factors affecting health-related quality of life in women with recurrent breast cancer in Korea. Qual Life Res. 2007;16(4):559-69.
25. Cheung WY, Le LW, Zimmermann C. Symptom clusters in patients with advanced cancers. Supp Care Cancer. 2009;17(9): 1223-30.
26. Kim SH, et al. Fatigue and depression in disease-free breast cancer survivors: prevalence, correlates and association with quality of life. J Pain Symptom Manage. 2008;35(6):644-55.